-
Alder Biopharma Surged 60% Following Phase 2 Results
Monday, March 28, 2016 - 11:15am | 272Read More...Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR), a clinical-stage biopharmaceutical company, surged higher by nearly 60 percent on Monday. Alder Biopharmaceuticals announced earlier in the morning positive top-line data from 2 clinical trials which studied its ALD403 product, an antibody...
-
Alder Biopharmaceuticals' New Drug Promises Migraine Relief, Stock Rally
Friday, June 5, 2015 - 1:21pm | 425Read More...Shares of clinical-stage biopharmaceutical company Alder Biopharmaceuticals Inc (NASDAQ: ALDR) are up more than 100 percent from the lows they made in late April this year and are currently trading near their all-time highs. One of the main reasons for this surge has been the promising data...
